Vaccine Shield: Combatting Meningitis Outbreak in Southeast England

The UK's health authorities have confirmed that the Bexsero vaccine can combat the meningitis strain causing an outbreak in southeast England. Two fatalities have been reported. To address this, thousands have received vaccinations and antibiotics, while more cases are under investigation. Health officials are expanding vaccination clinics as demand rises.

Britain's health authorities announced on Friday that initial laboratory findings indicate the vaccine offered to students should effectively combat the meningitis strain responsible for the outbreak in southeast England, which has tragically claimed two lives.

The UK Health Security Agency confirmed that this strain, identified within the ST-41/44 meningococci group, has previously circulated in the country. The agency expressed that the Bexsero vaccine's coverage of this strain offers significant reassurance, although further analysis is still underway.

So far, 2,360 individuals have received vaccinations, and about 9,840 antibiotic courses have been deployed as part of the response strategy. By Thursday evening, 18 cases were confirmed, with an additional 11 under investigation. Kent County Council's public health director, Anjan Ghosh, noted potential sporadic cases outside the region.